Done, mental health startup, investigated by DEA

[ad_1]

The U.S. Drug Enforcement Agency is investigating mental health startup Done for its prescription of controlled substances, according to a news story.

The Wall Street Journal first reported on the investigation.

According to the report, the DEA’s Diversion Control Division is leading the investigation into Done and fellow online mental health startup Cerebral about their prescription of Adderall and other controlled substances.

A spokesperson from Done said the company has not “received any notifications from the DEA, Department of Justice, or any other federal agency regarding an investigation, request for records, or preservation of documents.”

Done’s spokesperson said the company does not treat or determine diagnoses of individuals with ADHD but provides a “platform that allows individuals to connect with qualified clinicians to both diagnose and treat ADHD patients.” The company said these clinicians are not employees or contractors.

A spokesperson from Cerebral said it does not comment on pending investigations, but added that the company is fully cooperating with any probe. A spokesperson for the DEA did not comment.

Download Modern Healthcare’s app to stay informed when industry news breaks.

Cerebral has been allegedly tied to multiple federal government investigations. In June, the U.S. Federal Trade Commission reportedly sent a letter to Cerebral requesting information on whether the company has continued to charge patients even after they’ve attempted to cancel their subscription. According to the report, the FTC asked Cerebral to preserve relevant documents.

Cerebral received a grand jury subpoena from the U.S. Attorney’s Office for the Eastern District of New York on May concerning an investigation into “possible violations of the Controlled Substances Act” related to how it prescribed medication for ADHD. It’s unclear if this investigation ties into the one reportedly by the DEA.

In response to the grand jury subpoena in May, Cerebral said it had not been accused of violating any laws. The company announced on the same day it would no longer prescribe certain controlled substances to treat ADHD. In late May, Walmart, CVS Health and other national pharmacy chains said they were going to stop filling ADHD meds from Cerebral and Done.

This story first appeared in Digital Health Business & Technology.

[ad_2]

Source link

slot gacor slot gacor togel macau slot hoki bandar togel slot dana slot mahjong link slot link slot777 slot gampang maxwin slot hoki slot mahjong slot maxwin slot mpo slot777 slot toto slot toto situs toto toto slot situs toto situs toto situs toto situs toto slot88 toto slot slot gacor thailand slot bet receh situs toto situs toto slot toto slot situs toto situs toto situs toto situs togel macau toto slot slot demo slot pulsa slot pragmatic situs toto deposit dana 10k surga slot toto slot link situs toto situs toto slot situs toto situs toto slot777 slot gacor situs toto slot slot pulsa 10k toto togel situs toto slot situs toto slot gacor terpercaya slot dana slot gacor pay4d agen sbobet kedai168 kedai168 deposit pulsa situs toto slot pulsa situs toto slot pulsa situs toto situs toto situs toto slot dana toto slot situs toto slot pulsa toto slot situs toto slot pulsa situs toto situs toto